F
Fadi Nabhan
Researcher at Ohio State University
Publications - 28
Citations - 708
Fadi Nabhan is an academic researcher from Ohio State University. The author has contributed to research in topics: Thyroid cancer & Thyroid nodules. The author has an hindex of 11, co-authored 28 publications receiving 518 citations. Previous affiliations of Fadi Nabhan include University of Cincinnati Academic Health Center & The Ohio State University Wexner Medical Center.
Papers
More filters
Journal ArticleDOI
Multicenter Clinical Experience With the Afirma Gene Expression Classifier
Erik K. Alexander,Melanie Schorr,Joshua P. Klopper,Caroline S Kim,Jennifer A. Sipos,Fadi Nabhan,Charles Parker,David L. Steward,Susan J. Mandel,Bryan R. Haugen +9 more
TL;DR: These multicenter, clinical experience data confirm originally published Afirma GEC test performance and demonstrate its substantial impact on clinical care recommendations, and although nonsignificant site-to-site variation exists, such differences should be anticipated by the practicing clinician.
Journal ArticleDOI
Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules.
Mayumi Endo,Fadi Nabhan,Kyle Porter,Katie Roll,Lawrence A. Shirley,Irina Azaryan,Dena Tonkovich,Jeanette Perlick,Laura E. Ryan,Raheela Khawaja,Shumei Meng,John E. Phay,Matthew D. Ringel,Jennifer A. Sipos +13 more
TL;DR: Data from a single academic tertiary center shows an improved specificity and PPV while maintaining high sensitivity and NPV for GSC compared to GEC, likely indicating fewer false positive results.
Journal ArticleDOI
Thyroid nodules and cancer management guidelines: comparisons and controversies
Fadi Nabhan,Matthew D. Ringel +1 more
TL;DR: In this paper, the authors highlight similarities and differences between several of the most recently published guidelines focused on key areas of importance to clinical care and controversy and highlight key areas for future research to strengthen the data to support future guideline recommendations.
Journal ArticleDOI
Approach to Follow-Up of the Patient With Differentiated Thyroid Cancer and Positive Anti-Thyroglobulin Antibodies
Matthew D. Ringel,Fadi Nabhan +1 more
TL;DR: The data supporting monitoring and treatment paradigms for patients with anti-Tg antibodies are explored in a case-based manner and will stress areas where more evidence is needed to better inform clinicians regarding the management of patients with this challenging situation.
Journal ArticleDOI
Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma.
TL;DR: A case of Graves' disease diagnosed after initiation of ipilimumab in a patient with melanoma and total thyroidectomy and left neck dissection is reported as a definitive treatment for both hyperthyroidism and residual melanoma.